Cases & Deals

Synlico develops patent portfolio related to single-cell bioinformatics and AI-based drug discovery computational platforms

Client(s) Synlico Inc.

Jones Day is representing Synlico Inc. in establishing a global patent portfolio related to single-cell bioinformatics and causal artificial intelligence (AI) -based drug discovery computational platforms, which utilize deep generative models and causal structure discovery and inference to identify causal links between intracellular activities and cellular responses within a patient's microenvironment, predicting how cell modulation alters cellular behavior in patients.